. . . . . . . "[Considering the widespread use of aromatase inhibitors (AIs) in endocrine therapy as a first-line treatment for postmenopausal estrogen receptor ?-positive breast cancer patients, identifying deregulated expression levels of miRNAs in association with AI resistance is of utmost importance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:30+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .